Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

The US Laboratory Developed Tests (LDTs) Market to Contribute $3.08 Billion Revenue Share by 2029 - Personalized Medicines Boosting the Market Opportunities - Exclusive Focus Insight Report by Arizton

Focus Reports by Arizton (PRNewsfoto/Arizton Advisory & Intelligence)

News provided by

Arizton Advisory & Intelligence

May 08, 2024, 14:55 ET

Share this article

Share toX

Share this article

Share toX

CHICAGO, May 8, 2024 /PRNewswire/ -- According to Arizton's latest focus insight report, the US laboratory developed tests market is growing at a CAGR of 3.40% from 2023 to 2029.

To Know More, Click: https://www.focusreports.store/report/us-laboratory-developed-tests-market

Continue Reading
U.S. Laboratory Developed Tests (LDTs) Market - Focused Insights 2024-2029
U.S. Laboratory Developed Tests (LDTs) Market - Focused Insights 2024-2029

The U.S. Laboratory Developed Tests (LDTs) Market Report Scope

Report Attributes

Details

Market Size (2029)

USD 3.08 Billion

Market Size (2023)

USD 2.52 Billion

CAGR (2023-2029)

3.40 %

Historic Year 

2020-2022  

Base Year   

2023

Forecast Year   

2024-2029  


Personalized medicines are becoming the trademark of cancer treatment. It is a constantly evolving approach based on customized treatments based on individual genetic makeup. The FDA approved 12 personalized medications in 2019 to investigate and address the root causes of the diseases, thus combining precision medicine in clinical care. LDTs play a vital role in developing personalized medicine that are likely to prove promising means of tackling diseases through effective treatments. Biopharmaceutical companies have doubled their R&D investments in personalized drugs in the last few years, and they are further expected to increase their investments by 33% in the next five years. The rising demand for personalized medicine offers significant growth opportunities for the growth of the vendors operating in the laboratory developed tests market.

Key Points

  • In 2023, the immune and clinical chemistry segment held the largest market share, accounting for 38.25%, and is projected to grow at a CAGR of 3.16% over the forecast period. This growth is driven by the multitude of clinical chemistry tests available.
  • Regarding application, the oncology segment led the market in 2023, capturing 40.30% market share, and is expected to grow at a CAGR of 3.61% during the forecast period. This growth is fueled by the rising prevalence of cancer diseases and increased healthcare expenditure.

Competitive Landscape

Intense competition characterizes the laboratory developed tests (LDTs) market, driven by manufacturers and developers striving for innovation and distinctiveness. Among the approximately 267,000 lab facilities in the US, only 12,000 CLIA certified laboratories can develop and utilize LDTs. Furthermore, the expansion of operations by health system laboratories has increased competition for clinical laboratory testing from physicians within these health systems and unaffiliated physicians in their service areas. Investment and innovation in the Laboratory Developed Test (LDT) sector are on the rise, driven by the improving precision and efficacy of these tests in disease detection and diagnosis. Major independent laboratories such as LabCorp and Quest Diagnostics are significant players in the US market, alongside several international independent clinical laboratories competing with smaller domestic vendors. Notable competitors in the US clinical laboratory tests market include LabCorp, Quest Diagnostics, Sonic Healthcare, and OPKO Health.

To Know More, Click: https://www.focusreports.store/report/us-laboratory-developed-tests-market

Segmentation & Forecast

  • By Test
    • Clinical & Immunochemistry
    • Molecular Diagnostics
    • Microbiology
    • Others
  • By Application
    • Oncology
    • Rare & Genetic Disorders
    • Autoimmune Disorders
    • Infectious Diseases
    • Others

Vendors List

  • LabCorp
  • Eurofins
  • Mayo Clinic
  • OPKO Health Inc
  • Quest Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Accu Reference Medical Lab
  • ARUP Laboratories
  • Clinical Reference Laboratory
  • DaVita
  • Empire City Laboratories
  • Fresenius Medical Care
  • Laboratory of Florida LLC
  • HealthTrackRx
  • Millennium Health
  • U.S. Specialty Labs
  • NeoGenomics
  • Charles River Laboratories
  • Centers Laboratory
  • Qiagen
  • Fuller Laboratories
  • Unilab Corp
  • Bionano Laboratories
  • Cooper Clinics
  • U.R. Medicine Laboratories
  • Vista Clinical Laboratory

Key Questions Answered in the Report:

Q. How big is the U.S. laboratory developed tests market?
Q What is the growth rate of the U.S. laboratory developed tests market?
Q. What are the key trends in the U.S. laboratory developed tests (LDTs) market?

Table of Content

CHAPTER – 1: Laboratory Developed Tests Market Overview

  • Executive Summary
  • Key Findings

CHAPTER – 2: Laboratory Developed Tests Market

  • US: Projected Revenue of Laboratory Developed Tests Market (2020-2029; $Billions)

CHAPTER – 3: Laboratory Developed Tests Market Segmentation Data

  • US: Projected Revenue by Test Type (2020-2029; $Billions)
    • Clinical & Immunochemistry
    • Molecular Diagnostics
    • Microbiology
    • Others
  • U.S.: Projected Revenue by Application (2020-2029; $Billions)
    • Oncology
    • Rare & Genetic Disorders
    • Autoimmune Disorders
    • Infectious Diseases
    • Others

CHAPTER – 4: Laboratory Developed Tests Market Prospects & Opportunities

  • Laboratory Developed Tests Market Opportunities & Trends
  • Laboratory Developed Tests Market Drivers
  • Laboratory Developed Tests Market Constraints

CHAPTER – 5: Laboratory Developed Tests Industry Overview

  • Laboratory Developed Tests Market - Competitive Landscape
  • Laboratory Developed Tests Market – Key Vendor Profiles
  • Laboratory Developed Tests Market - Other Prominent Vendors
  • Laboratory Developed Tests Market - Key Strategic Recommendations

CHAPTER – 6: Appendix

  • Research Methodology
  • Abbreviations
  • About Arizton

About Focused Reports by Arizton          

Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.   

About Us:                                                          

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                             

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                              

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.          

Contact Us:         
Call: +1-312-235-2040                                                    
          +1 302 469 0707                                                  
Mail: [email protected]        
Website: https://www.focusreports.store/

Photo: https://mma.prnewswire.com/media/2407699/Aritzon_Laboratory_Tests_Market_Infographic.jpg
Link: https://mma.prnewswire.com/media/2326840/4694489/Focus_Reports_Logo.jpg

SOURCE Arizton Advisory & Intelligence

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.